BIOTRONIK has received European approval for its implantable device home monitoring system. Designed to avoid regular visits to the clinic by patients wearing company’s ICD’s, CRT’s, and similar devices, the system sends readings from the chest straight to your doc over the cellular phone network.
BIOTRONIK Home Monitoring® is the first and only fully wireless, mobile remote monitoring system for patients with implantable cardiac devices on the market today. This newly authorized EU approval for BIOTRONIK Home Monitoring® is based on the landmark TRUST Trial which proved that BIOTRONIK Home Monitoring® can safely and effectively replace conventional in-hospital device follow-up visits. Patients can be remotely monitored securely through the BIOTRONIK Home Monitoring® wireless system with only one annual in-clinic visit. In addition, the TRUST trial also demonstrated that BIOTRONIK Home Monitoring® with its automatic daily surveillance provides early detection and notification of both symptomatic and asymptomatic arrhythmic events and device system anomalies allowing for earlier physician intervention than conventional in-hospital follow-ups.
By extending the time between routine in-hospital visits for periods up to 12 months, remote device follow-up with BIOTRONIK Home Monitoring® reduces the number of physician consultations in often overburdened cardiology hospitals without negatively impacting patients’ quality of care or safety. Physicians and clinic staff benefit from reduced workloads for routine cases, which allow them to afford greater attention to patients who urgently require a consultation for diagnostics and treatment.
These new approvals are applicable across the entire BIOTRONIK product portfolio of pacemakers, implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT) devices with BIOTRONIK Home Monitoring®.
Product page: BIOTRONIK Home Monitoring…
Press release: BIOTRONIK Home Monitoring Receives Industry’s First Approval to Safely Replace Hospital Visits for Cardiac Device Follow-ups…
Flashback: BIOTRONIK Cardiac Monitoring Going Worldwide.